Skip to main content
. 2017 Oct 9;8(55):94235–94246. doi: 10.18632/oncotarget.21670

Figure 6. HDAC5 disrupts the interaction between MKL1 and p65.

Figure 6

(A) FLAG-tagged MKL1 and V5-tagged p65 were transfected into HEK293 cells in the presence or absence of HDAC5. Immunoprecipitation was performed with anti-FLAG. (B) THP-1 cells were transfected with siRNA targeting HDAC5 or scrambled siRNA (SCR) followed by treatment with TNF-α (10ng/ml). Immunoprecipitation was performed with anti-MKL1. (C) THP-1 cells were transfected with HDAC5 expression construct or an empty vector (EV) followed by treatment with TNF-α (10ng/ml). Re-ChIP assays were performed with indicated antibodies. (D) THP-1 cells were transfected with siRNA targeting HDAC5 or scrambled siRNA (SCR) followed by treatment with TNF-α (10ng/ml). Re-ChIP assays were performed with indicated antibodies. (E) A schematic model. All experiments have been repeated three times.